Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
WindMIL Therapeutics
company
About
WindMIL Therapeutics translates novel insights in bone marrow immunology into life-saving cell therapies for cancer patients.
- Princeton,New Jersey,United States
- 11 - 50
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- $32.50M
- Industries
- Biotechnology,Medical Device,Therapeutics
- Founded date
- Jan 1, 2015
- Number Of Employee
- 11 - 50
- Operating Status
- Active
- Legal Name
- WindMIL Therapeutics, Inc.
WindMIL Therapeutics translates novel insights in bone marrow immunology into life-saving cell therapies for cancer patients. The company leveraging its proprietary platform to develop a novel class of cell therapies called MILs (Marrow Infiltrating Lymphocytes) derived from memory T cells found in the bone marrow. WindMIL Therapeutics was established in 2015 and is based in Baltimore, MD.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
$42.50M
WindMIL Therapeutics has raised a total of
$42.50M
in funding over 2 rounds. Their latest funding was raised on
Jun 18, 2018 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jun 18, 2018 | Series B | $32.50M | 5 |
Qiming Venture Partners
|
— | Detail |
| Apr 7, 2016 | Series A | $10M | 1 |
Scott H. Cohen
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
2
6
WindMIL Therapeutics is funded by 6 investors.
Qiming Venture Partners
and Scott H. Cohen
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Qiming Venture Partners
|
Yes | Series B |
|
Scott H. Cohen
|
Yes | Series A |
Medivate Partners
|
— | Series B |
Camden Partners
|
— | Series B |
Domain Associates
|
— | Series B |
FoxKiser
|
— | Series B |
Employee Profiles
Number of Employee Profiles
5
WindMIL Therapeutics has 5 current employee profiles, including
Executive Brian Halak
Executive
Board member
Board member
Executive
Executive
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
